Author: Bryan D. Hayes, PharmD
Attending Pharmacist, Emergency Medicine and Toxicology, Massachusetts General Hospital; Assistant Professor of EM, Harvard Medical School
2020 ACLS Guidelines Medication Recommendations Part 1: Vasopressors and Non-Vasopressors During Cardiac Arrest
Today’s pearl reviews part of the 2020 ACLS Guidelines.
What’s new and what has stayed the same?
Continue reading “2020 ACLS Guidelines Medication Recommendations Part 1: Vasopressors and Non-Vasopressors During Cardiac Arrest”Sulfamethoxazole/Trimethoprim Drug Interactions Important for EM Clinicians
Today’s pearl highlights two interactions that are important for Emergency Medicine clinicians to know.
What are the risks? How common are they?
Continue reading “Sulfamethoxazole/Trimethoprim Drug Interactions Important for EM Clinicians”Antibiotic Effects on Oral Contraceptives
Today’s pearl addresses a misconception regarding a drug interaction between oral contraceptives and antibiotics.
Are back-up methods of contraception required? Does this apply to all antibiotics?
Continue reading “Antibiotic Effects on Oral Contraceptives”Neuropsychiatric Side Effects of Steroids
Today’s pearl reviews the adverse neuropsychiatric effects associated with the use of steroids.
Can steroids alter mentation? What is the incidence? Are there any risk factors?
Continue reading “Neuropsychiatric Side Effects of Steroids”Magnesium for Atrial Fibrillation Rate Control in the ED
Today’s pearl is a continuation of Pearl 42: Medication Pearls for Atrial Fibrillation Management in the ED and reviews the role of magnesium for the treatment of atrial fibrillation.
Does magnesium reduce HR? How much and how fast to administer?
Continue reading “Magnesium for Atrial Fibrillation Rate Control in the ED”Medication Pearls for Atrial Fibrillation Management in the ED
Today’s pearl highlights 5 main points related to the treatment of atrial fibrillation.
Should you give a beta blocker or a calcium channel blocker? What dose should you use?
Continue reading “Medication Pearls for Atrial Fibrillation Management in the ED”QTc Prolongation and Torsades de Pointes with Droperidol in the Emergency Department
How common is QTc prolongation or Torsades de Pointes (TdP) in ED patients getting droperidol?
Actually quite rare!
In 30,000 patients, TdP occurred once (the patient had multiple risk factors and TdP didn’t reoccur when re-challenged).
Prior data covered in 2015 @aaeminfo position statement.
